Published in Biomaterials on July 01, 1996
Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface (2010) 2.69
Biomaterials in orthopaedics. J R Soc Interface (2008) 1.78
Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineering. Biomaterials (2007) 1.67
Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size. Tissue Eng Part B Rev (2013) 1.60
Active scaffolds for on-demand drug and cell delivery. Proc Natl Acad Sci U S A (2010) 1.58
Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. J R Soc Interface (2009) 1.39
Injectable preformed scaffolds with shape-memory properties. Proc Natl Acad Sci U S A (2012) 1.28
Macroscale delivery systems for molecular and cellular payloads. Nat Mater (2013) 1.25
Cell colonization in degradable 3D porous matrices. Cell Adh Migr (2008) 1.22
Composite scaffolds for cartilage tissue engineering. Biorheology (2008) 1.18
Advanced material strategies for tissue engineering scaffolds. Adv Mater (2009) 1.18
Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developments. J R Soc Interface (2011) 1.18
Extracellular vesicles: potential roles in regenerative medicine. Front Immunol (2014) 1.17
3D biofabrication strategies for tissue engineering and regenerative medicine. Annu Rev Biomed Eng (2014) 1.12
Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts. Biotechnol Bioeng (2012) 1.09
Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv Drug Deliv Rev (2012) 1.07
Layered PLG scaffolds for in vivo plasmid delivery. Biomaterials (2008) 1.04
Spatiotemporal control over growth factor signaling for therapeutic neovascularization. Adv Drug Deliv Rev (2007) 1.03
Microsphere-based scaffolds for cartilage tissue engineering: using subcritical CO(2) as a sintering agent. Acta Biomater (2009) 1.01
Chitosan-Based Inverse Opals: Three-Dimensional Scaffolds with Uniform Pore Structures for Cell Culture. Adv Mater (2009) 1.01
Tubular perfusion system culture of human mesenchymal stem cells on poly-L-lactic acid scaffolds produced using a supercritical carbon dioxide-assisted process. J Biomed Mater Res A (2012) 0.98
Effect of 3D-scaffold formation on differentiation and survival in human neural progenitor cells. Biomed Eng Online (2010) 0.98
Therapeutic angiogenesis: controlled delivery of angiogenic factors. Ther Deliv (2012) 0.97
Novel polymeric scaffolds using protein microbubbles as porogen and growth factor carriers. Tissue Eng Part C Methods (2010) 0.96
Bone tissue engineering scaffolding: computer-aided scaffolding techniques. Prog Biomater (2014) 0.93
Supercritical carbon dioxide: putting the fizz into biomaterials. Philos Trans A Math Phys Eng Sci (2006) 0.91
The contribution of plasmid design and release to in vivo gene expression following delivery from cationic polymer modified scaffolds. Biomaterials (2009) 0.90
A one-step method to fabricate PLLA scaffolds with deposition of bioactive hydroxyapatite and collagen using ice-based microporogens. Acta Biomater (2009) 0.90
Preparation of 3-D regenerated fibroin scaffolds with freeze drying method and freeze drying/foaming technique. J Mater Sci Mater Med (2006) 0.90
Growth, differentiation, transplantation and survival of human skeletal myofibers on biodegradable scaffolds. Biomaterials (2008) 0.89
Hydrogel macroporosity and the prolongation of transgene expression and the enhancement of angiogenesis. Biomaterials (2012) 0.89
Effect of polycaprolactone scaffold permeability on bone regeneration in vivo. Tissue Eng Part A (2011) 0.89
Poly (D,L-lactide)/nano-hydroxyapatite composite scaffolds for bone tissue engineering and biocompatibility evaluation. J Mater Sci Mater Med (2007) 0.88
A bioengineered peripheral nerve construct using aligned peptide amphiphile nanofibers. Biomaterials (2014) 0.88
Designing bioactive delivery systems for tissue regeneration. Ann Biomed Eng (2010) 0.88
Chitosan-based scaffolds for bone tissue engineering. J Mater Chem B Mater Biol Med (2014) 0.88
Hydrogels to modulate lentivirus delivery in vivo from microporous tissue engineering scaffolds. Drug Deliv Transl Res (2011) 0.87
In Situ Porous Structures: A Unique Polymer Erosion Mechanism in Biodegradable Dipeptide-based Polyphosphazene and Polyester Blends Producing Matrices for Regenerative Engineering. Adv Funct Mater (2010) 0.86
Fabrication and characterization of porous poly(L-lactide) scaffolds using solid-liquid phase separation. J Mater Sci Mater Med (2008) 0.85
Osteoblasts responses to three-dimensional nanofibrous gelatin scaffolds. J Biomed Mater Res A (2012) 0.84
Mammalian cell survival and processing in supercritical CO(2). Proc Natl Acad Sci U S A (2006) 0.84
Synthesis and characterization of poly(L-lactic acid) membranes: studies in vivo and in vitro. J Mater Sci Mater Med (2003) 0.83
Angiogenic therapy for cardiac repair based on protein delivery systems. Heart Fail Rev (2012) 0.83
Effects of nanoimprinted patterns in tissue-culture polystyrene on cell behavior. J Vac Sci Technol A (2005) 0.83
Tailoring of processing parameters for sintering microsphere-based scaffolds with dense-phase carbon dioxide. J Biomed Mater Res B Appl Biomater (2012) 0.83
Poly(ε-caprolactone) and poly(D,L-lactic acid-co-glycolic acid) scaffolds used in bone tissue engineering prepared by melt compression-particulate leaching method. J Mater Sci Mater Med (2011) 0.83
Three-dimensional scaffold of electrosprayed fibers with large pore size for tissue regeneration. Acta Biomater (2010) 0.83
An osteoconductive, osteoinductive, and osteogenic tissue-engineered product for trauma and orthopaedic surgery: how far are we? Stem Cells Int (2011) 0.82
Scaffolds for bone tissue engineering fabricated from two different materials by the rapid prototyping technique: PCL versus PLGA. J Mater Sci Mater Med (2012) 0.82
Structure prediction, molecular dynamics simulation and docking studies of D-specific dehalogenase from Rhizobium sp. RC1. Int J Mol Sci (2012) 0.81
Fabrication of tissue engineering scaffolds through solid-state foaming of immiscible polymer blends. Biofabrication (2011) 0.81
Enhanced differentiation of human embryonic stem cells on extracellular matrix-containing osteomimetic scaffolds for bone tissue engineering. Tissue Eng Part C Methods (2014) 0.81
The future of carbon dioxide for polymer processing in tissue engineering. Tissue Eng Part B Rev (2013) 0.81
Physiochemical, optical and biological activity of chitosan-chromone derivative for biomedical applications. Int J Mol Sci (2012) 0.81
Microporous poly(L-lactic acid) membranes fabricated by polyethylene glycol solvent-cast/particulate leaching technique. Tissue Eng Part C Methods (2009) 0.80
Laminar silk scaffolds for aligned tissue fabrication. Macromol Biosci (2012) 0.80
Gelatine/PLLA sponge-like scaffolds: morphological and biological characterization. J Mater Sci Mater Med (2007) 0.80
At the edge of translation - materials to program cells for directed differentiation. Oral Dis (2010) 0.80
Cell-friendly inverse opal-like hydrogels for a spatially separated co-culture system. Macromol Rapid Commun (2014) 0.80
PLLA-PEG-TCH-labeled bioactive molecule nanofibers for tissue engineering. Int J Nanomedicine (2011) 0.80
3-D PLLA scaffolds formation by a supercritical freeze extraction assisted process. J Mater Sci Mater Med (2013) 0.80
Poly (lactic acid)-based biomaterials for orthopaedic regenerative engineering. Adv Drug Deliv Rev (2016) 0.78
Adhesion and morphology of fibroblastic cells cultured on different polymeric biomaterials. J Mater Sci Mater Med (2002) 0.78
Regenerative therapy and tissue engineering for the treatment of end-stage cardiac failure: new developments and challenges. Biomatter (2013) 0.78
Marine algae sulfated polysaccharides for tissue engineering and drug delivery approaches. Biomatter (2013) 0.78
Fabrication of porous scaffolds with a controllable microstructure and mechanical properties by porogen fusion technique. Int J Mol Sci (2011) 0.78
Computer aided biomanufacturing of mechanically robust pure collagen meshes with controlled macroporosity. Biofabrication (2015) 0.78
Biocompatibility and biodegradation studies of PCL/β-TCP bone tissue scaffold fabricated by structural porogen method. J Mater Sci Mater Med (2012) 0.78
Scaffold-mediated BMP-2 minicircle DNA delivery accelerated bone repair in a mouse critical-size calvarial defect model. J Biomed Mater Res A (2016) 0.78
Ultrasonic monitoring of foamed polymeric tissue scaffold fabrication. J Mater Sci Mater Med (2008) 0.77
Highly porous drug-eluting structures: from wound dressings to stents and scaffolds for tissue regeneration. Biomatter (2013) 0.77
Effects of baicalin-modified poly(D,L-lactic acid) surface on the behavior of osteoblasts. J Mater Sci Mater Med (2003) 0.77
Modeling and Validation of Multilayer Poly(Lactide-Co-Glycolide) Scaffolds for In Vitro Directed Differentiation of Juxtaposed Cartilage and Bone. Tissue Eng Part A (2015) 0.76
In-vitro anticancer and antimicrobial activities of PLGA/silver nanofiber composites prepared by electrospinning. J Mater Sci Mater Med (2013) 0.76
Solvent-free Fabrication of Tissue Engineering Scaffolds with Immiscible Polymer Blends. Int J Polym Mater (2014) 0.75
Synthesis of and in vitro and in vivo evaluation of a novel TGF-β1-SF-CS three-dimensional scaffold for bone tissue engineering. Int J Mol Med (2016) 0.75
Fabrication and characterization of poly(DL-lactic-co-glycolic acid)/zirconia-hybridized amorphous calcium phosphate composites. J Biomater Sci Polym Ed (2006) 0.75
Application of bone growth factors--the potential of different carrier systems. Oral Maxillofac Surg (2010) 0.75
Water as foaming agent for open cell polyurethane structures. J Mater Sci Mater Med (2004) 0.75
BIORESORBABLE POLYMERIC MENISCAL PROSTHESIS: STUDY IN RABBITS. Rev Bras Ortop (2015) 0.75
Gelatine/PLLA sponge-like scaffolds: morphological and biological characterization. J Mater Sci Mater Med (2006) 0.75
Use of triethylcitrate plasticizer in the production of poly-L-lactic acid implants with different degradation times. J Mater Sci Mater Med (2003) 0.75
3D PLLA/ibuprofen composite scaffolds obtained by a supercritical fluids assisted process. J Mater Sci Mater Med (2013) 0.75
A novel akermanite/poly (lactic-co-glycolic acid) porous composite scaffold fabricated via a solvent casting-particulate leaching method improved by solvent self-proliferating process. Regen Biomater (2017) 0.75
Solvent free production of porous PDLLA/calcium carbonate composite scaffolds improves the release of bone growth factors. Oral Maxillofac Surg (2014) 0.75
Therapeutic PCL scaffold for reparation of resected osteosarcoma defect. Sci Rep (2017) 0.75
Fabrication of Porous Materials from Natural/Synthetic Biopolymers and Their Composites. Materials (Basel) (2016) 0.75
Preparation of collagen modified photopolymers: a new type of biodegradable gel for cell growth. J Mater Sci Mater Med (2010) 0.75
Tissue engineering. Science (1993) 19.65
Biodegradable long-circulating polymeric nanospheres. Science (1994) 7.46
Functional arteries grown in vitro. Science (1999) 6.08
A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials (2003) 3.63
Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics (1989) 3.38
Large porous particles for pulmonary drug delivery. Science (1997) 3.35
Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast Reconstr Surg (1997) 2.93
New challenges in biomaterials. Science (1994) 2.85
Polymers for the sustained release of proteins and other macromolecules. Nature (1976) 2.81
Stimulation of neurite outgrowth using an electrically conducting polymer. Proc Natl Acad Sci U S A (1997) 2.74
Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature (1992) 2.73
Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res (1991) 2.70
Photoencapsulation of chondrocytes in poly(ethylene oxide)-based semi-interpenetrating networks. J Biomed Mater Res (2000) 2.67
Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res (2000) 2.64
Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet (1999) 2.62
Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science (1983) 2.47
Biodegradable polymer scaffolds for tissue engineering. Biotechnology (N Y) (1994) 2.47
A controlled-release microchip. Nature (1999) 2.39
Bioengineered teeth from cultured rat tooth bud cells. J Dent Res (2004) 2.31
Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci U S A (1993) 2.27
Enzymatic degradation of glycosaminoglycans. Crit Rev Biochem Mol Biol (1995) 2.21
Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc Natl Acad Sci U S A (1991) 2.19
Bioreactor cultivation conditions modulate the composition and mechanical properties of tissue-engineered cartilage. J Orthop Res (1999) 2.19
Lipid-based nanotherapeutics for siRNA delivery. J Intern Med (2010) 2.15
Formulation and physical characterization of large porous particles for inhalation. Pharm Res (1999) 2.10
Ultrasound-mediated transdermal protein delivery. Science (1995) 2.07
Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering. Biotechnol Prog (1998) 2.03
Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library. J Am Chem Soc (2001) 2.02
Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol (1989) 2.01
Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng (1999) 2.00
Transdermal photopolymerization for minimally invasive implantation. Proc Natl Acad Sci U S A (1999) 1.99
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric (2013) 1.94
Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am J Physiol Heart Circ Physiol (2001) 1.90
Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1993) 1.88
Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics. J Pharm Sci (1980) 1.86
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85
Morphologic and mechanical characteristics of engineered bovine arteries. J Vasc Surg (2001) 1.84
Switching from differentiation to growth in hepatocytes: control by extracellular matrix. J Cell Physiol (1992) 1.79
Isolations of a cartilage factor that inhibits tumor neovascularization. Science (1976) 1.79
Identification of an inhibitor of neovascularization from cartilage. Science (1990) 1.78
Functional living trileaflet heart valves grown in vitro. Circulation (2000) 1.77
Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative. Hypertension (2000) 1.77
Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials (1996) 1.76
Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg (1998) 1.76
Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proc Natl Acad Sci U S A (2001) 1.76
Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng (2000) 1.71
Cytoskeletal filament assembly and the control of cell spreading and function by extracellular matrix. J Cell Sci (1995) 1.71
Tissue engineering of complex tooth structures on biodegradable polymer scaffolds. J Dent Res (2002) 1.61
Integrin binding and cell spreading on extracellular matrix act at different points in the cell cycle to promote hepatocyte growth. Mol Biol Cell (1994) 1.61
The stimulation of DNA synthesis and cell division in chondrocytes and 3T3 cells by a growth factor isolated from cartilage. Exp Cell Res (1977) 1.60
A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J Pharm Sci (1997) 1.58
Laminated three-dimensional biodegradable foams for use in tissue engineering. Biomaterials (1993) 1.57
Transdermal monitoring of glucose and other analytes using ultrasound. Nat Med (2000) 1.57
Tissue engineering of cartilage in space. Proc Natl Acad Sci U S A (1997) 1.57
Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg (1988) 1.55
Congenital diaphragmatic hernia: arterial structural changes and persistent pulmonary hypertension after surgical repair. J Pediatr (1985) 1.52
Transdermal photopolymerization of poly(ethylene oxide)-based injectable hydrogels for tissue-engineered cartilage. Plast Reconstr Surg (1999) 1.52
Tissue-engineered growth of cartilage: the effect of varying the concentration of chondrocytes seeded onto synthetic polymer matrices. Int J Oral Maxillofac Surg (1994) 1.52
Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res (1997) 1.51
[MRI with supermagnetic iron particles versus double-spiral CT in identification of malignant liver lesions]. Rofo (1998) 1.51
Fallopian tube torsion: laparoscopic evaluation and treatment of a rare gynecological entity. J Am Board Fam Pract (2001) 1.49
Controlled and modulated release of basic fibroblast growth factor. Biomaterials (1991) 1.48
A polymer foam conduit seeded with Schwann cells promotes guided peripheral nerve regeneration. Tissue Eng (2000) 1.48
Collagen in tissue-engineered cartilage: types, structure, and crosslinks. J Cell Biochem (1998) 1.47
Tissue engineering: the challenges ahead. Sci Am (1999) 1.45
Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg (1991) 1.44
Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res (1993) 1.44
Bacterial inactivation by using near- and supercritical carbon dioxide. Proc Natl Acad Sci U S A (1999) 1.43
Purification and characterization of heparinase from Flavobacterium heparinum. J Biol Chem (1985) 1.43
Tissue engineering: current state and prospects. Annu Rev Med (2001) 1.42
Transdermal drug delivery using low-frequency sonophoresis. Pharm Res (1996) 1.42
Chondrogenesis in a cell-polymer-bioreactor system. Exp Cell Res (1998) 1.42
Protein stability in controlled-release systems. Nat Biotechnol (2000) 1.41
Preliminary studies of tissue-engineered intestine using isolated epithelial organoid units on tubular synthetic biodegradable scaffolds. Transplant Proc (1997) 1.41
Silk based biomaterials to heal critical sized femur defects. Bone (2006) 1.40
Responsive polymeric delivery systems. Adv Drug Deliv Rev (2001) 1.40
Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc Natl Acad Sci U S A (1989) 1.39
Fabrication of degradable polymer scaffolds to direct the integration and differentiation of retinal progenitors. Biomaterials (2005) 1.38
Glucocorticoids prolong rat sciatic nerve blockade in vivo from bupivacaine microspheres. Anesthesiology (1996) 1.37
Recent advances in pulmonary drug delivery using large, porous inhaled particles. J Appl Physiol (1985) (1998) 1.36
Electrically conducting polymers can noninvasively control the shape and growth of mammalian cells. Proc Natl Acad Sci U S A (1994) 1.33
Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. J Biomed Mater Res (1985) 1.33
Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials (2004) 1.32
Tissue engineering: a 21st century solution to surgical reconstruction. Ann Thorac Surg (2001) 1.32
Tissue engineering: current state and perspectives. Appl Microbiol Biotechnol (2004) 1.32
Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine (1994) 1.31
Biomimetic approach to cardiac tissue engineering. Philos Trans R Soc Lond B Biol Sci (2007) 1.31
A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J Pharm Sci (1995) 1.30
Fabrication of nanostructures of polyethylene glycol for applications to protein adsorption and cell adhesion. Nanotechnology (2005) 1.30
Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels. Ann Surg (1998) 1.29
Congenital diaphragmatic hernia--a tale of two cities: the Boston experience. J Pediatr Surg (1997) 1.28
Mammalian chondrocytes expanded in the presence of fibroblast growth factor 2 maintain the ability to differentiate and regenerate three-dimensional cartilaginous tissue. Exp Cell Res (1999) 1.28